Autogramins inhibit the cholesterol-transfer protein GRAMD1A, involved in autophagy regulation Sep. 2, 2019 No Comments
Transgenic expression of human STING mutant in hematopoietic cells provides murine SAVI model Aug. 26, 2019 No Comments
Much bias, little binary: in sex differences in gene expression, "the whole genome is in the game" July 30, 2019 No Comments
Mallinckrodt deal signals turnaround for Silence at potential $693M per target July 22, 2019 By Nuala Moran No Comments LONDON – Silence Therapeutics plc has finally secured a deal to transform its fortunes, signing up Mallinckrodt plc in a potential $693 million-per-asset collaboration to develop siRNA therapeutics that block the complement inflammatory cascade.Read More